Trials / Completed
CompletedNCT05693389
Efficacy of Acceptance and Commitment Therapy on Impulsivity and Suicidality Among Clients With Bipolar Disorders
The Efficacy of Acceptance and Commitment Therapy on Impulsivity and Suicidality Among Clients With Bipolar Disorders: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Psychiatric nurses face a huge challenge in predicting and preventing suicide behaviour in their patients with bipolar disorders, but it may also be one of the most accurate measures of how well their clinical care is working. In addition to, high impulsivity scores are associated with increased overall functional impairment, a higher number of episodes with early onset, and a higher number of past suicide attempts, as well as increased substance intake. Thus, this study aimed at evaluating the efficacy acceptance and commitment therapy on impulsivity and suicidality among bipolar clients. research hypnosis * Clients who engaged in acceptance and commitment therapy had less impulsivity than the control group. * Clients who engaged in acceptance and commitment therapy had less suicidality than the control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | acceptance and commitment therapy | ACT attempts to encourage psychological flexibility, acceptance of one's own experiences, and dedication to behaviours that are consistent with one's own values. ACT therapies focus on six key processes to improve psychological flexibility: engagement with the present moment, acceptance, defusion, self as context, values clarification, and committed action. |
| OTHER | routine hospital care | the patients with bipolar disorders who receive routine pharmacological treatment |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2022-11-15
- Completion
- 2022-12-20
- First posted
- 2023-01-23
- Last updated
- 2023-01-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05693389. Inclusion in this directory is not an endorsement.